{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T21:55:02Z","timestamp":1793829302624,"version":"4.6.1"},"reference-count":104,"publisher":"Informa UK Limited","issue":"7","license":[{"start":{"date-parts":[[2022,6,2]],"date-time":"2022-06-02T00:00:00Z","timestamp":1654128000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Opinion on Drug Delivery"],"published-print":{"date-parts":[[2022,7,3]]},"DOI":"10.1080\/17425247.2022.2084530","type":"journal-article","created":{"date-parts":[[2022,5,30]],"date-time":"2022-05-30T04:15:20Z","timestamp":1653884120000},"page":"755-769","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":21,"title":["Inhaled antifungal therapy: benefits, challenges, and clinical applications"],"prefix":"10.1080","volume":"19","author":[{"given":"Kazuhiro","family":"Ito","sequence":"first","affiliation":[{"name":"National Heart and Lung Institute, Imperial College","place":["London, UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2022,6,2]]},"reference":[{"key":"e_1_3_4_3_1","unstructured":"Gaffi L. Global action fund for fungal infections. 2021 [cited 26 May 2022]; Available from: https:\/\/gaffi.org\/"},{"key":"e_1_3_4_4_1","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.00140-18"},{"key":"e_1_3_4_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjms.2020.12.009"},{"key":"e_1_3_4_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-2600(21)00138-7"},{"key":"e_1_3_4_7_1","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/43.3.321"},{"key":"e_1_3_4_8_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41564-020-00837-0"},{"key":"e_1_3_4_9_1","doi-asserted-by":"publisher","DOI":"10.1055\/s-0039-3401992"},{"key":"e_1_3_4_10_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13601-020-00353-8"},{"key":"e_1_3_4_11_1","doi-asserted-by":"publisher","DOI":"10.2471\/BLT.11.089441"},{"key":"e_1_3_4_12_1","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.2008-740ST"},{"key":"e_1_3_4_13_1","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00162912"},{"key":"e_1_3_4_14_1","doi-asserted-by":"publisher","DOI":"10.3109\/02770903.2012.662568"},{"key":"e_1_3_4_15_1","doi-asserted-by":"publisher","DOI":"10.1378\/chest.09-2996"},{"key":"e_1_3_4_16_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2222.2012.03987.x"},{"key":"e_1_3_4_17_1","doi-asserted-by":"publisher","DOI":"10.1378\/chest.12-1363"},{"key":"e_1_3_4_18_1","doi-asserted-by":"publisher","DOI":"10.1080\/14740338.2017.1270264"},{"key":"e_1_3_4_19_1","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01123-08"},{"key":"e_1_3_4_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2352-3026(21)00232-5"},{"key":"e_1_3_4_21_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.idc.2021.03.005"},{"key":"e_1_3_4_22_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11046-021-00560-2"},{"key":"e_1_3_4_23_1","doi-asserted-by":"publisher","DOI":"10.2174\/1381612826666210101153547"},{"key":"e_1_3_4_24_1","doi-asserted-by":"publisher","DOI":"10.1615\/CritRevTherDrugCarrierSyst.2018025781"},{"key":"e_1_3_4_25_1","doi-asserted-by":"publisher","DOI":"10.1111\/ina.12020"},{"key":"e_1_3_4_26_1","doi-asserted-by":"publisher","DOI":"10.1093\/mmy\/myw117"},{"key":"e_1_3_4_27_1","doi-asserted-by":"publisher","DOI":"10.1186\/2045-7022-4-14"},{"key":"e_1_3_4_28_1","doi-asserted-by":"publisher","DOI":"10.1093\/mmy\/myy076"},{"key":"e_1_3_4_29_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmi.2018.01.002"},{"issue":"7","key":"e_1_3_4_30_1","first-page":"548","article-title":"Invasive Aspergillosis as an Under-recognized Superinfection in COVID-19","volume":"7","author":"Thompson IIIGR","year":"2020","unstructured":"Thompson IIIGR, Cornely OA, Pappas PG, et al. Invasive Aspergillosis as an Under-recognized Superinfection in COVID-19. Open Forum Infect Dis. 2020;7(7):548.","journal-title":"Open Forum Infect Dis"},{"key":"e_1_3_4_31_1","doi-asserted-by":"publisher","DOI":"10.1078\/1438-4639-00106"},{"key":"e_1_3_4_32_1","doi-asserted-by":"publisher","DOI":"10.1111\/tid.13333"},{"key":"e_1_3_4_33_1","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.06.00074705"},{"key":"e_1_3_4_34_1","doi-asserted-by":"publisher","DOI":"10.1155\/2012\/903659"},{"key":"e_1_3_4_35_1","doi-asserted-by":"publisher","DOI":"10.1111\/cea.12426"},{"key":"e_1_3_4_36_1","doi-asserted-by":"publisher","DOI":"10.3109\/13693786.2010.485582"},{"issue":"2","key":"e_1_3_4_37_1","first-page":"48","article-title":"Aspergillus fumigatus Protease Alkaline Protease 1 (Alp1): a New Therapeutic Target for Fungal Asthma","volume":"6","author":"Druey KM","year":"2020","unstructured":"Druey KM, McCullough M, Krishnan R. Aspergillus fumigatus Protease Alkaline Protease 1 (Alp1): a New Therapeutic Target for Fungal Asthma. J Fungi (Basel). 2020 Jun 16;6(2):48.","journal-title":"J Fungi (Basel)"},{"key":"e_1_3_4_38_1","doi-asserted-by":"publisher","DOI":"10.1086\/600070"},{"key":"e_1_3_4_39_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.imbio.2015.01.002"},{"key":"e_1_3_4_40_1","doi-asserted-by":"publisher","DOI":"10.3109\/1040841X.2012.754401"},{"key":"e_1_3_4_41_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40265-019-01127-8"},{"key":"e_1_3_4_42_1","doi-asserted-by":"publisher","DOI":"10.1111\/myc.12786"},{"key":"e_1_3_4_43_1","doi-asserted-by":"publisher","DOI":"10.1002\/ppul.23505"},{"key":"e_1_3_4_44_1","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.02.00248002"},{"key":"e_1_3_4_45_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciw326"},{"key":"e_1_3_4_46_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.addr.2015.03.002"},{"key":"e_1_3_4_47_1","doi-asserted-by":"publisher","DOI":"10.1513\/AnnalsATS.201307-231OC"},{"key":"e_1_3_4_48_1","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkr567"},{"key":"e_1_3_4_49_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11046-015-9885-2"},{"issue":"1","key":"e_1_3_4_50_1","first-page":"69","article-title":"Antifungal Effects of PC945, a Novel Inhaled Triazole, on Candida albicans Pulmonary Infection in Immunocompromised Mice","volume":"2","author":"Nishimoto Y","year":"2021","unstructured":"Nishimoto Y, Ito K, Kimura G, et al. Antifungal Effects of PC945, a Novel Inhaled Triazole, on Candida albicans Pulmonary Infection in Immunocompromised Mice. J Exp Pathol. 2021;2(1):69.","journal-title":"J Exp Pathol"},{"key":"e_1_3_4_51_1","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00124-17"},{"key":"e_1_3_4_52_1","first-page":"87","article-title":"In vitro and in vivo antifungal profile of a novel and long acting inhaled azole, PC945, on Aspergillus fumigatus infection","volume":"1","author":"Colley T","year":"2017","unstructured":"Colley T, Alanio A, Kelly SL, et al. In vitro and in vivo antifungal profile of a novel and long acting inhaled azole, PC945, on Aspergillus fumigatus infection. Antimicrob Agents Chemother. 2017;1:87.","journal-title":"Antimicrob Agents Chemother"},{"key":"e_1_3_4_53_1","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkz302"},{"key":"e_1_3_4_54_1","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01941-17"},{"key":"e_1_3_4_55_1","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.39.8.1784"},{"key":"e_1_3_4_56_1","doi-asserted-by":"publisher","DOI":"10.1111\/myc.12653"},{"key":"e_1_3_4_57_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13054-021-03728-w"},{"key":"e_1_3_4_58_1","doi-asserted-by":"publisher","DOI":"10.1111\/myc.12996"},{"key":"e_1_3_4_59_1","doi-asserted-by":"publisher","DOI":"10.3109\/02770903.2015.1127935"},{"key":"e_1_3_4_60_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2015.02.023"},{"key":"e_1_3_4_61_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1399-3062.2011.00661.x"},{"key":"e_1_3_4_62_1","doi-asserted-by":"publisher","DOI":"10.1159\/000327802"},{"key":"e_1_3_4_63_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.healun.2009.11.603"},{"key":"e_1_3_4_64_1","doi-asserted-by":"publisher","DOI":"10.1086\/586739"},{"key":"e_1_3_4_65_1","doi-asserted-by":"publisher","DOI":"10.1136\/thx.45.6.447"},{"key":"e_1_3_4_66_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.healun.2020.09.015"},{"key":"e_1_3_4_67_1","doi-asserted-by":"publisher","DOI":"10.1111\/ajt.14580"},{"issue":"11","key":"e_1_3_4_68_1","first-page":"3654","article-title":"Aerosolized amphotericin B inhalations as prophylaxis of invasive aspergillus infections during prolonged neutropenia: results of a prospective randomized multicenter trial","volume":"93","author":"Schwartz S","year":"1999","unstructured":"Schwartz S, Behre G, Heinemann V, et al. Aerosolized amphotericin B inhalations as prophylaxis of invasive aspergillus infections during prolonged neutropenia: results of a prospective randomized multicenter trial. Blood. 1999 Jun 1;93(11):3654\u20133661.","journal-title":"Blood"},{"key":"e_1_3_4_69_1","doi-asserted-by":"publisher","DOI":"10.3109\/02770903.2014.958853"},{"key":"e_1_3_4_70_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.healun.2008.11.004"},{"key":"e_1_3_4_71_1","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01657-08"},{"key":"e_1_3_4_72_1","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00163511"},{"key":"e_1_3_4_73_1","doi-asserted-by":"publisher","DOI":"10.1111\/bcpt.12820"},{"key":"e_1_3_4_74_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcf.2013.10.014"},{"key":"e_1_3_4_75_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11095-006-9904-6"},{"key":"e_1_3_4_76_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejpb.2012.09.018"},{"key":"e_1_3_4_77_1","first-page":"9","volume-title":"6th Advances Against Aspergillosis 2014","author":"Hirano K","year":"2014","unstructured":"Hirano K, Izumikawa M, Yoshida K. Efficacy of Antifungal Therapy with Inhaled Itraconazole against Murine Invasive Pulmonary Aspergillosis with Itraconazole-Low Susceptible Aspergillus fumigatus. 6th Advances Against Aspergillosis 2014. Madrid 2014:9."},{"key":"e_1_3_4_78_1","first-page":"147","volume-title":"8th Advances Against Aspergillosis","author":"Curran A","year":"2018","unstructured":"Curran A, Perry J, Hava D. Efficacy of PUR1900, an inhaled antifungal therapy, in a Guinea pig model of invasive pulmonary aspergillosis. 8th Advances Against Aspergillosis. Lisbon 2018:147."},{"key":"e_1_3_4_79_1","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics12121161"},{"key":"e_1_3_4_80_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drudis.2018.05.017"},{"key":"e_1_3_4_81_1","doi-asserted-by":"publisher","DOI":"10.1517\/17425247.2016.1114603"},{"key":"e_1_3_4_82_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12951-020-00731-1"},{"key":"e_1_3_4_83_1","doi-asserted-by":"publisher","DOI":"10.1089\/jamp.2014.1155"},{"key":"e_1_3_4_84_1","doi-asserted-by":"publisher","DOI":"10.1186\/2008-2231-20-85"},{"key":"e_1_3_4_85_1","first-page":"87","article-title":"Itraconazole-loaded nanostructured lipid carriers (NLC) for pulmonary treatment of aspergillosis in falcons","volume":"1","author":"Pardeike J","year":"2016","unstructured":"Pardeike J, Weber S, Zarfl HP, et al. Itraconazole-loaded nanostructured lipid carriers (NLC) for pulmonary treatment of aspergillosis in falcons. Eur J Pharm Biopharm. 2016;1:87.","journal-title":"Eur J Pharm Biopharm"},{"key":"e_1_3_4_86_1","doi-asserted-by":"publisher","DOI":"10.15171\/apb.2016.009"},{"key":"e_1_3_4_87_1","doi-asserted-by":"publisher","DOI":"10.1021\/acs.molpharmaceut.1c00978"},{"issue":"45","key":"e_1_3_4_88_1","first-page":"S333","article-title":"DELIVERY OF PUR1900 ENABLES HIGH LUNG EXPOSURE OF ITRACONAZOLE RELATIVE TO ORAL DOSING","volume":"51","author":"Curran AK","year":"2016","unstructured":"Curran AK, McIntyre KT, Tracy HS, et al. DELIVERY OF PUR1900 ENABLES HIGH LUNG EXPOSURE OF ITRACONAZOLE RELATIVE TO ORAL DOSING. Pediatr Pulmonol. 2016;51(S45):S333.","journal-title":"Pediatr Pulmonol"},{"key":"e_1_3_4_89_1","doi-asserted-by":"publisher","DOI":"10.1111\/bcp.14166"},{"key":"e_1_3_4_90_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejpb.2012.04.019"},{"key":"e_1_3_4_91_1","first-page":"A958","article-title":"Edry\u2122 an innovative dry powder technology evaluated via functional respiratory imaging (FRI)","volume":"48","author":"Caponetti G","year":"2016","unstructured":"Caponetti G, Maggi L, Sardina M, et al. Edry\u2122 an innovative dry powder technology evaluated via functional respiratory imaging (FRI). Eur Respir J. 2016;48:A958.","journal-title":"Eur Respir J"},{"issue":"4","key":"e_1_3_4_92_1","first-page":"965","article-title":"PC945, a Novel Inhaled Antifungal Agent, for the Treatment of Respiratory Fungal Infections","volume":"6","author":"Murray A","year":"2020","unstructured":"Murray A, Cass L, Ito K, et al. PC945, a Novel Inhaled Antifungal Agent, for the Treatment of Respiratory Fungal Infections. J Fungi (Basel). 2020 Dec 17;6(4):965.","journal-title":"J Fungi (Basel)"},{"key":"e_1_3_4_93_1","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.02280-16"},{"key":"e_1_3_4_94_1","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00124-17"},{"key":"e_1_3_4_95_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-45890-w"},{"key":"e_1_3_4_96_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.healun.2020.09.015"},{"key":"e_1_3_4_97_1","doi-asserted-by":"publisher","DOI":"10.1002\/prp2.690"},{"key":"e_1_3_4_98_1","unstructured":"FDA. Workshop: addressing Challenges in Inhaled Antifungal Drug Development. 2020 [cited 26 May 2022]; Available from: https:\/\/www.fda.gov\/drugs\/news-events-human-drugs\/addressing-challenges-inhaled-antifungal-drug-development-09252020-09252020."},{"key":"e_1_3_4_99_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0209652"},{"key":"e_1_3_4_100_1","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-61779-539-8_24"},{"key":"e_1_3_4_101_1","first-page":"abstract 33","volume-title":"AAAM2020","author":"Daly L","year":"2020","unstructured":"Daly L, Lucas KA, Colley T, et al. Synergic anti-fungal activity of topical PC945, a novel inhaled azole, with systemic echinocandin on Aspergillus fumigatus in vitro human alveoli model. AAAM2020. Lugano. 2020;abstract 33."},{"key":"e_1_3_4_102_1","first-page":"7","article-title":"Posaconazole-Loaded Leukocytes as a Novel Treatment Strategy Targeting Invasive Pulmonary Aspergillosis","volume":"5","author":"Baistrocchi SR","year":"2016","unstructured":"Baistrocchi SR, Lee MJ, Lehoux M, et al. Posaconazole-Loaded Leukocytes as a Novel Treatment Strategy Targeting Invasive Pulmonary Aspergillosis. J Infect Dis. 2016;5:7.","journal-title":"J Infect Dis"},{"key":"e_1_3_4_103_1","first-page":"abstract 68","volume-title":"AAAM2020","author":"Ito K","year":"2020","unstructured":"Ito K, Kizawa Y, Kimura G, et al. Accumulation of a novel inhaled azole, PC945 in alveolar cells in temporally neutropenic immunocompromised mice infected with Aspergillus fumigatus. AAAM2020. Lugano. 2020:abstract 68."},{"key":"e_1_3_4_104_1","unstructured":"FDA. Nonclinical Safety Evaluation of Reformulated Drug Products and Products Intended for Administration by an Alternate Route Guidance for Industry and Review Staff. 2015. [Cited 26 May 2022]. Available from: https:\/\/www.fda.gov\/regulatory-information\/search-fda-guidance-documents\/nonclinical-safety-evaluation-reformulated-drug-products-and-products-intended-administration"},{"key":"e_1_3_4_105_1","first-page":"S1198-743X(19)3","article-title":"High-volume culture and quantitative real-time PCR for the detection of Aspergillus in sputum","author":"Vergidis P","year":"2019","unstructured":"Vergidis P, Moore CB, Novak-Frazer L, et al. High-volume culture and quantitative real-time PCR for the detection of Aspergillus in sputum. Clin Microbiol Infect. 2019. S1198-743X(19)30619\u20136","journal-title":"Clin Microbiol Infect"},{"issue":"5","key":"e_1_3_4_106_1","first-page":"698","article-title":"Detection of Aspergillus DNA in BALF by Real-time PCR and Galactomannan Antigen for the Early Diagnosis of Chronic Pulmonary Aspergillosis","volume":"51","author":"Ye F","year":"2021","unstructured":"Ye F, Zeng P, Li Z, et al. Detection of Aspergillus DNA in BALF by Real-time PCR and Galactomannan Antigen for the Early Diagnosis of Chronic Pulmonary Aspergillosis. Ann Clin Lab Sci. 2021 Sep;51(5):698\u2013704.","journal-title":"Ann Clin Lab Sci"}],"container-title":["Expert Opinion on Drug Delivery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/17425247.2022.2084530","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T01:04:37Z","timestamp":1770944677000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/17425247.2022.2084530"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,2]]},"references-count":104,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2022,7,3]]}},"alternative-id":["10.1080\/17425247.2022.2084530"],"URL":"https:\/\/doi.org\/10.1080\/17425247.2022.2084530","relation":{},"ISSN":["1742-5247","1744-7593"],"issn-type":[{"value":"1742-5247","type":"print"},{"value":"1744-7593","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6,2]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=iedd20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=iedd20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2021-12-23","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-05-27","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-06-02","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}